52496 Federal Register / Vol. 74, No. 196 / Tuesday, October 13, 2009 / Notices 

3507(j) of the Paperwork Reduction Act 

of 1995 (PRA) (44 U.S.C. 3507(j) and 5 

CFR 1320.13). On June 22, 2009, the 

President signed FSPTCA into law 

(Public Law 111–31). Section 101 of 

FSPTCA amends the Federal Food, 

Drug, and Cosmetic Act (the act) by 

adding, among other things, new 

sections 904 (21 U.S.C. 394) and 905 (21 

U.S.C. 395). 

FDA originally identified its plan to 

collect the information submission 

requirements of sections 905, 904(a)(1), 

and 904(a)(4) through a single electronic 

portal. In addition to the electronic 

portal, FDA also plans to provide a 

paper based form to collect this 

information for those individuals who 

choose not to use the electronic portal. 

FDA originally planned to launch the 

electronic portal for the collection of 

this information on October 1, 2009. 

FDA now plans to launch the electronic 

portal for the collection of this 

information on November 2, 2009. If 

FDA were to use the normal PRA 

clearance procedures, the availability of 

the electronic portal and the submission 

of information by respondents could not 

begin with adequate time to meet the 

respective statutory deadlines 

(December 22, 2009, for section 904, and 

December 31, 2009, for section 905). 

Dated: October 6, 2009. 

David Horowitz, 

Assistant Commissioner for Policy. 

[FR Doc. E9–24543 Filed 10–9–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; DMID Clinical Research 

Operations and Management Support. 

Date: November 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Roosevelt Room, Rockville, 

MD 20852. 

Contact Person: Clayton C. Huntley, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID/DHHS, 

6700B Rockledge Drive, MSC 7616, Bethesda, 

MD 20892–7616, (301) 451–2570, 

chuntley@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Exploratory Investigation in 

Food Allergy (R21). 

Date: November 19–20, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Sujata Vijh, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, NIAID/ 

NIH/DHHS, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892, 301–594–0985, 

vijhs@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 5, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24472 Filed 10–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Interagency Autism Coordinating 

Committee (IACC) Subcommittee for 

Planning the Annual Strategic Planning 

Process. 

The purpose of the Subcommittee for 

Planning the Annual Strategic Planning 

Process is to plan the process for 

annually updating the IACC Strategic 

Plan for Autism Spectrum Disorder 

Research. The Subcommittee meeting 

will be conducted as a telephone 

conference call. This meeting is open to 

the public through a conference call 

phone number. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Type of meeting: Subcommittee for 

planning the Annual Strategic Planning 

Process. 

Date: October 15, 2009. 

Time: 2 p.m. to 4 p.m. Eastern Time. 

Agenda: To discuss the outcome of the 

IACC Scientific Workshop that took place on 

September 30 and October 1, 2009. 

Conference Call: Dial: 888–455–2920. 

Access code: 1050786. 

Contact Person: Ms. Lina Perez, Office of 

Autism Research Coordination, Office of the 

Director, National Institute of Mental Health, 

NIH, 6001 Executive Boulevard, NSC, Room 

8200, Bethesda, MD 20892–9669. Phone: 

301–443–6040.E-mail: 

IACCPublicInquiries@mail.nih.gov. 

Please Note: The meeting will be open to 

the public through a conference call phone 

number. Individuals who participate using 

this service and who need special assistance, 

such as captioning of the conference call or 

other reasonable accommodations, should 

submit a request at least 4 days prior to the 

meeting. 

Members of the public who participate 

using the conference call phone number will 

be able to listen to the meeting but will not 

be heard. This phone call may end prior to 

or later than 4 p.m., depending on the needs 

of the subcommittee. 

This meeting is being published less than 

15 days prior to the meeting due to the 

timing limitations for the Subcommittee to 

review and discuss the outcomes from the 

IACC Workshop and to be able to present 

their proposals at the IACC meeting on 

October 23. 

Information about the IACC is available on 

the Web site: http://www.iacc.hhs.gov. 

Dated: October 5, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24473 Filed 10–9–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


erowe on DSK5CLS3C1PROD with NOTICES